ZNF671 and neoplasm: Moreover, survival analysis stratifying patients based on the median ZNF671 tumor expression demonstrated that patients whose primary tumors had low ZNF671 expression (less than the median expression) showed a significantly worse overall survival when compared to those with higher ZNF671 expression (Figure 2A, Log-rank, p < 0.05).